Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIofina Regulatory News (IOF)

Share Price Information for Iofina (IOF)

Share Price is delayed by 15 minutes
Get Live Data
44.50    -0.50 (-1.11%)
Bid:
44.00
Ask:
45.00
Spread: 1.00 (2.273%)
Market Cap: £85.38m
IOF Live PriceLast checked at - London Stock Exchange

Intraday Iofina Share Chart

Market Update

25 Feb 2020 12:00

RNS Number : 0738E
Iofina PLC
25 February 2020
 

 

25 February 2020

 

Iofina plc

("Iofina", the "Group", or the "Company")

(LSE AIM: IOF)

 

 Market Update

 

IofinaEX update

 

Construction of IO#8 on budget and on track

 

Iodine prices continue to rise

 

Iofina plc, specialists in the exploration and production of iodine and manufacturers of specialty chemical products, is pleased to provide an update to the market regarding its ongoing operations and new projects.

 

IofinaEX

IofinaEX, continues to make progress in developing its technology to isolate specialty chemicals from hemp. Active trials continue at our facility in Kentucky whose Hemp Processor/Handler license was recently renewed.

 

As part of the initial work to set up IofinaEX, the Group has been evaluating business opportunities in Belize and elsewhere. Following this early evaluation process, which has been carried out at minimal expense, the Directors have concluded that the best strategy to grow IofinaEX would be to initially focus on the excellent CBD opportunities it has in the USA, a highly regulated market which Iofina currently operates in and understands well. This will also allow Iofina to continue the strong progress being made within its core iodine and specialty chemical businesses in the USA.

 

IofinaEX continues to develop its strategy in the CBD/Hemp space and will update the market as the business plan evolves in this dynamic market. Fully developing and communicating this business plan has taken longer than anticipated as the CBD/hemp global market is changing rapidly. Furthermore, despite now focusing on USA opportunities, IofinaEX will still continue to evaluate prospects outside of the USA as they present themselves.

 

IO#8

The construction of IO#8 continues to progress well, on budget and on track to be brought online likely in April 2020. Installation of steel, tanks, electrical and plumbing has progressed well, with other key components expected to be fitted within the next few weeks. Once in production, IO#8 will contribute fully to the Group's H2 2020 production output adding to Iofina's four operating iodine plants in Oklahoma.

 

http://www.rns-pdf.londonstockexchange.com/rns/0738E_1-2020-2-25.pdf

 

 

Figure 1. Construction of IO#8 in western Oklahoma

Iodine market

Iodine prices rose over 20% in 2019 and continue to rise in early 2020. The spot price now sits in the mid $30's per kilogram and is rising towards the upper $30's as a result of the continuing demand for iodine and a tightness in supply. The Directors believe that iodine prices will continue to increase in 2020. To date we have not seen any impact from the COVID-19 virus outbreak to the overall iodine market and specifically to the Group's sales or supply chain.

 

 

Commenting, President and CEO of Iofina, Dr. Tom Becker, stated: "As we approach the completion of IO#8 we are excited to see the plant come online in the months ahead, and to begin contributing to the Group's 2020 iodine output.

 

"Iodine markets have remained strong, after a solid 2019, and the Directors are confident that prices will continue to favour the Group as it progresses through 2020.

 

"Having now refocused efforts for IofinaEX, along with the Group's core iodine business lines to concentrate on opportunities in the USA, the Directors are confident that Group resources will be properly utilised, that risk has been minimised and Iofina will maximise the value delivered for shareholders."

 

Enquiries:

 

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

 

Christopher Raggett/Giles Rolls/Matthew Radley (corporate finance)

Camille Gochez (ECM)

finnCap Ltd

Tel: +44 (0)20 7220 0500

 

Media Contact:

Charles Goodwin/Joe Burgess

Yellow Jersey PR Limited

Tel: +44 (0)20 3004 9512

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated Company that specialises in the production of iodine and the manufacturing of specialty chemical products. As the second largest producer of iodine in North America, it comprises three USA entities; Iofina Resources, Iofina Chemical and IofinaEX.

 

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

 

Iofina Resources

Iofina Resources develops, builds, owns and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina currently operates four producing IOsorb® plants in Oklahoma, is building a fifth site, and is consistently using technology and innovation to improve and expand its operations.

 

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals derived from raw iodine, as well as non-iodine based products for over 35 years.

 

IofinaEX

Iofina's newest subsidiary, IofinaEX, is fully licensed to process hemp in the state of Kentucky and is exploring the isolation of specialty chemical products from hemp, a rapidly expanding market.

 

www.iofina.com

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDSEWFFIESSELE
Date   Source Headline
22nd Dec 20147:00 amRNSMarket update
16th Dec 20147:00 amRNSBoard Change
8th Dec 20147:00 amRNSExercise of Options and Total Voting Rights
28th Nov 20144:35 pmRNSPrice Monitoring Extension
17th Nov 20147:00 amRNSIssue of Patent and Market Update
30th Oct 20147:00 amRNSExercise of Options and Total Voting Rights
15th Oct 20147:00 amRNSTotal Voting Rights
10th Oct 20142:56 pmRNSTR-1: Notification of Major Interest in Shares
8th Oct 20149:15 amRNSTR-1: Notification of Major Interest in Shares
6th Oct 20147:00 amRNSProduction & Water Permit Update
30th Sep 20147:00 amRNSInterim Results
18th Sep 20147:00 amRNSProduction Update
5th Sep 20147:00 amRNSAppointment of CEO
14th Aug 20147:00 amRNSJuly Production Update
9th Jul 20147:00 amRNSJune Production Update
18th Jun 20147:00 amRNSExercise of Options and Total Voting Rights
10th Jun 20143:42 pmRNSResult of AGM & Appointment of Directors
3rd Jun 20147:00 amRNSIodine Production Update
16th May 20141:58 pmRNSNotice of AGM
6th May 20147:01 amRNSApril Iodine Production Update
29th Apr 20147:00 amRNSSuccessful Completion of Convertible Bond
28th Apr 20147:00 amRNSBoard Changes
25th Apr 20147:00 amRNSFinal Results
23rd Apr 20147:00 amRNSProduction Update
22nd Apr 20147:01 amRNSWater Project Update
15th Apr 20144:40 pmRNSAppointment of Director (amended)
14th Apr 20147:00 amRNSProduction Update
10th Apr 20148:03 amRNSAppointment of Director
7th Apr 20147:00 amRNSHolding(s) in Company
2nd Apr 20144:39 pmRNSHolding(s) in Company
27th Mar 20147:00 amRNSMarket update
20th Mar 20147:00 amRNSResignation and appointment of Director
7th Mar 20147:00 amRNSAmendment to the terms of Convertible Bond
28th Feb 20147:01 amRNSIO#4 and IO#5 Update
3rd Feb 20147:00 amRNSNon-Core Water Project Update
29th Jan 20147:00 amRNSOperational Update
28th Jan 20147:00 amRNSHolding(s) in Company
13th Jan 20147:00 amRNSChange of Adviser
6th Jan 201410:12 amRNSDirector Transfer of Shares
23rd Dec 20137:00 amRNSWater Project Update
17th Dec 20133:35 pmRNSDirector Dealing
17th Dec 201310:27 amRNSDirector Dealing
17th Dec 20137:00 amRNS2013 Review and 2014 Outlook
13th Dec 20132:55 pmRNSWater Permit
29th Nov 20137:00 amRNSDirectors' Disclosure
22nd Nov 20137:00 amRNSBoard Change
20th Nov 20137:00 amRNSOperational Update
12th Nov 20137:01 amRNSGrant of Options to Directors
5th Nov 20131:45 pmRNSChange of Registered Office
31st Oct 20137:00 amRNSCommissioning of IO#3 iodine extraction plant

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.